{"news_desk": "National", "print_page": "19", "section_name": "U.S.", "subsection_name": null, "byline": {"original": "By ROBERT PEAR", "person": [{"rank": 1, "role": "reported", "firstname": "Robert", "organization": "", "lastname": "PEAR"}]}, "abstract": "Stephen J Ubl is appointed president and chief executive of Pharmaceutical Research and Manufacturers of America, becoming top lobbyist defending drug industry against charges that pharmaceutical companies charge too much for medicines.", "type_of_material": "News", "word_count": "385", "lead_paragraph": "Stephen J. Ubl is known in Washington for his deep knowledge of health policy, shrewd political instincts and low-key manner.", "pub_date": "2015-09-26T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Drug Companies Hire New Lobbyist to Answer Critics", "print_headline": "Drug Companies Bring On a New Lobbyist "}, "snippet": "Stephen J. Ubl is known in Washington for his deep knowledge of health policy, shrewd political instincts and low-key manner.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/09/26/us/drug-companies-hire-new-lobbyist-to-answer-critics.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Ubl, Stephen J (1969- )", "name": "persons"}, {"rank": "2", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Pharmaceutical Research and Manufacturers of America", "name": "organizations"}, {"rank": "4", "is_major": "Y", "value": "Lobbying and Lobbyists", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Merck & Company Inc", "name": "organizations"}], "blog": [], "_id": "5605d33238f0d809f2db1f19", "source": "The New York Times"}